Business
Fredun Pharmaceuticals Net Profit Rises 64% YoY in Q1 FY26
[ad_1]
Mumbai (Maharashtra) [India], July 31: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), is one of the Leading Pharmaceuticals Formulation manufacturing companies in India. Diversified into Generics, Cosmeceuticals, Nutraceuticals, Mobility and Animal Healthcare Products, has reported its Unaudited financials for Q1 FY26.
Key Financial Highlights
| Particulars (₹ Cr) | Q1 FY26 | Q1 FY25 | YoY |
| Total Income | 119.86 | 78.81 | 52.08% |
| EBITDA | 16.99 | 10.48 | 62.15% |
| EBITDA Margin (%) | 14.18 |
[ad_2]
Source link
You must be logged in to post a comment Login